Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:27447114  

ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome.

J Zak | V Vives | D Szumska | A Vernet | J E Schneider | P Miller | E A Slee | S Joss | Y Lacassie | E Chen | L F Escobar | M Tucker | A S Aylsworth | H A Dubbs | A T Collins | J Andrieux | A Dieux-Coeslier | E Haberlandt | D Kotzot | D A Scott | M J Parker | Z Zakaria | Y S Choy | D Wieczorek | A M Innes | K R Jun | S Zinner | F Prin | C A Lygate | P Pretorius | J A Rosenfeld | T J Mohun | X Lu
Cell death and differentiation | 2016

Chromosomal abnormalities are implicated in a substantial number of human developmental syndromes, but for many such disorders little is known about the causative genes. The recently described 1q41q42 microdeletion syndrome is characterized by characteristic dysmorphic features, intellectual disability and brain morphological abnormalities, but the precise genetic basis for these abnormalities remains unknown. Here, our detailed analysis of the genetic abnormalities of 1q41q42 microdeletion cases identified TP53BP2, which encodes apoptosis-stimulating protein of p53 2 (ASPP2), as a candidate gene for brain abnormalities. Consistent with this, Trp53bp2-deficient mice show dilation of lateral ventricles resembling the phenotype of 1q41q42 microdeletion patients. Trp53bp2 deficiency causes 100% neonatal lethality in the C57BL/6 background associated with a high incidence of neural tube defects and a range of developmental abnormalities such as congenital heart defects, coloboma, microphthalmia, urogenital and craniofacial abnormalities. Interestingly, abnormalities show a high degree of overlap with 1q41q42 microdeletion-associated abnormalities. These findings identify TP53BP2 as a strong candidate causative gene for central nervous system (CNS) defects in 1q41q42 microdeletion syndrome, and open new avenues for investigation of the mechanisms underlying CNS abnormalities.

Pubmed ID: 27447114

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: R01 MH092513
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH115993
  • Agency: British Heart Foundation, United Kingdom
    Id: RE/08/004
  • Agency: British Heart Foundation, United Kingdom
    Id: RG/13/8/30266
  • Agency: NICHD NIH HHS, United States
    Id: N01 HD023343
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/11/50/29038
  • Agency: Wellcome Trust, United Kingdom

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


International Mouse Phenotyping Consortium (IMPC) (tool)

RRID:SCR_006158

Center that produces knockout mice and carries out high-throughput phenotyping of each line in order to determine function of every gene in mouse genome. These mice will be preserved in repositories and made available to scientific community representing valuable resource for basic scientific research as well as generating new models for human diseases.

View all literature mentions